Cytotoxic T Lymphocytes to An Unmutated Tumor Rejection Antigen P1A: Normal Development but Restrained Effector Function In Vivo

Unmutated tumor antigens are chosen as primary candidates for tumor vaccine because of their expression on multiple lineages of tumors. A critical issue is whether unmutated tumor antigens are expressed in normal cells, and if so, whether such expression imposes special restrictions on cytotoxic T l...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarma, Supria, Guo, Yong, Guilloux, Yannik, Lee, Cheng, Bai, Xue-Feng, Liu, Yang
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1999
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2192944/
https://www.ncbi.nlm.nih.gov/pubmed/10049945

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2192944/
https://www.ncbi.nlm.nih.gov/pubmed/10049945

Ejemplares similares